Latest news
LTR Pharma Achieves 93% Response Rate in 147-Patient Real-World SPONTAN® Study - Kalkine MediaKalkine Media · Tue, 11 Aug 2026 06:17:24 GMTLTR Pharma reports real-world data for ED treatment - The AustralianThe Australian · Tue, 11 Aug 2026 05:51:00 GMTLTR Pharma Reports 93% SPONTAN Response in Real-World ED Cohort - TradingViewTradingView · Tue, 11 Aug 2026 03:57:00 GMTLTR Pharma (ASX:LTP) posts 93% response in 147-patient SPONTAN study as US launch nears - Stocks Down UnderStocks Down Under · Tue, 11 Aug 2026 00:16:18 GMTLTR Pharma Reports 93% Response Rate in 147-Patient SPONTAN® Real-World Study - KalkineKalkine · Mon, 10 Aug 2026 23:15:02 GMT